Immunohistochemistry PDL1 SP142 Test
Introduction to the Immunohistochemistry PDL1 SP142 Test
The Immunohistochemistry PDL1 SP142 Test is an essential diagnostic procedure used to evaluate the expression of Programmed Death-Ligand 1 (PD-L1) in tumor tissues. This test plays a pivotal role in oncology, particularly in the management of cancers where PD-L1 expression can influence treatment decisions. Understanding PD-L1 levels helps oncologists tailor immunotherapy treatments that are more likely to be effective for individual patients.
What the Test Measures
This test specifically measures the presence and intensity of PD-L1 protein expression in cancer tissues. PD-L1 is a protein that can inhibit the immune response, allowing cancer cells to evade detection and destruction by the immune system. By assessing PD-L1 levels, healthcare providers can determine the likelihood of response to certain immunotherapies, such as checkpoint inhibitors.
Who Should Consider This Test?
Patients diagnosed with cancer, particularly those with tumors that may express PD-L1, should consider this test. Symptoms that may warrant testing include:
- Unexplained weight loss
- Persistent coughing or difficulty breathing
- Fatigue
- Pain or discomfort in specific areas
Additionally, individuals with risk factors such as a family history of cancer or exposure to carcinogens should consult their oncologist about the necessity of this test.
Benefits of Taking the Test
- Guides treatment decisions: Helps oncologists identify the most effective immunotherapy options.
- Personalized medicine: Allows for tailored treatment plans based on individual tumor characteristics.
- Improves outcomes: Increases the chances of successful treatment by aligning therapies with tumor biology.
- Early detection: Can aid in identifying aggressive cancers that may require immediate intervention.
Understanding Your Results
Results from the Immunohistochemistry PDL1 SP142 Test are interpreted by a qualified pathologist. Generally, higher levels of PD-L1 expression correlate with a better response to immunotherapy. However, it is essential to discuss your results with your oncologist, who will provide guidance on the next steps based on your specific situation.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry PDL1 SP142 Test | 230000 NGN | 300000 NGN |
Booking the Test
To book the Immunohistochemistry PDL1 SP142 Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your test and answering any questions you may have.
Test Parameters
Turnaround Time: Sample Daily by 6 pm; Report Block: 5 days; Tissue Biopsy: 5 days; Tissue Large Complex: 7 days.
Sample Type: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.
This test is performed by specialists in the field of oncology and histology, ensuring accurate and reliable results to guide your cancer treatment journey.
